Shahla Romal

Shahla Romal is a Researcher at Erasmus MC specializing in organoid-based disease modeling. Her work spans oncology, virology, and infectious disease research with significant contributions to bladder cancer, hepatitis B, and malaria pathogenesis studies.

Her research focuses on advanced organoid platforms for disease modeling and drug discovery. Key interests include developing patient-derived tumoroid systems for bladder cancer, hepatitis B virus infection models using human liver organoids, and 3D platforms for malaria liver-stage research. Her work bridges translational medicine and molecular therapeutics, with emphasis on identifying novel drug targets and optimizing culture methodologies.

Analysis of her publication record (2022-2025) reveals strong focus on organoid technology applications across multiple disease contexts. Her research demonstrates consistent innovation in in vitro infection modeling (hepatitis B, malaria), cancer therapeutic target identification (bladder cancer), and methodological optimization for organoid culture systems. The work shows significant interdisciplinary collaboration across virology, oncology, and pharmacology domains.

Her research has received attention through 10 news outlets, 24 social media mentions (including X and Bluesky), and engagement from 28 Mendeley readers, indicating substantial scientific impact.

Romal actively collaborates on grant-funded research in organoid technology development and disease modeling, with recent work supported through institutional and likely national funding mechanisms focused on translational medical research. Her laboratory environment centers on advanced 3D tissue culture platforms and molecular analysis of disease mechanisms using patient-derived models.